Platinum resistance - Globe Thesis

Keyword [Platinum resistance] Result: 41 - 60 \| Page: 3 of 4
41.	Study On The Mechanism Of TRP14 Modulating Platinum-resistance In Ovarian Cancer Via Autophagy
42.	Biological Function And Clinical Characteristics Of PRC1 In High-grade Serous Ovarian Cancer
43.	Analysis Of Factors Related To Recurrence Of Platinum Resistant Epithelial Ovarian Cancer
44.	Bioinformatic Screening And Prognostic Analysis Of Platinum Resistance-associated Genes In High-grade Serous Ovarian Cancer
45.	Clinical Analysis Of Platinum-resistance Recurrence In Advanced Epithelial Ovarian Cancer
46.	MicroRNA Biomarker Discovery For Predicting Platinum Resistance In Ovarian Cancer
47.	The Molecular Mechanism Of TP53 K351N Mutant In Platinum-resistance In Epithelial Ovarian Cancer
48.	The Study On The Effect And Mechanism Of SRD5A3 Promoting The Malignant Behavior Of High Serous Ovarian Carcinoma
49.	The Relationship Between ERCC1 Expression In Circulating Tumor Cells And Prognosis Of Ovarian Cancer
50.	Retrospectively Analysis Of The Relationship Between XRCC1 And GSTP1 Gene Polymorphism And Epithelial Ovarian Cancer And The Efficacy Of Platinum-based Drugs
51.	Down-regulation Of Dicer1 Expression Leads To Platinum Resistance In Ovarian Cancer
52.	The Effect Of Neoadjuvant Chemotherapy On Platinum Resistance And Prognosis In Advanced Epithelial Ovarian Cancer
53.	Research On The Relationship Between Serum HE4 And Prognosis Of Epithelial Ovarian Cancer
54.	To Explore The Effect And Mechanism Of TLR4/Nanog/ABCF2 Pathway In Reversing Platinum Resistance Of Gastric Cancer Cells By Polyene Phosphatidylcholine In The Nude Mouse Model
55.	Correlation Between Twist Expression In Epithelial Ovarian Cancer And Chemotherapy Resistance And Prognosis
56.	Analysis Of Clinical Factors Related To Recurrence Of Platinum Resistance In Ovarian Cancer
57.	Correlation Between Serum CA125 And Platinum Resistance Recurrence And Prognosis In Patients With Ovarian Cancer
58.	Relationship Between Expression Of RASSF1A And WT-1 Protein And Recurrent Epithelial Ovarian Cancer
59.	The Effects And Mechanism Of Kallistatin In The Development Of High-grade Serous Ovarian Cancer
60.	The cellular pharmacology and cytotoxic activity of cisplatin are modulated by the copper transporter ATP7A
<<First <Prev Next> Last>> Jump to